RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

首次发布于 2015 年 6 月 15 日

MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)

计划入组 48 人 · 首次发布于 2019 年 2 月 25 日

VitaFlow LIBERTY Europe

计划入组 122 人 · 首次发布于 2024 年 8 月 2 日

BCM-899

BCM-894

BCM-857

BCM Resources Corp

MOVEMBER EUROPE

United Kingdom

CEPHEID EUROPE

France

Vaximm Secures Potential $835M Deal with BCM Europe for Oral Cancer Immunotherapy Platform VXM01

OSR Holdings Subsidiary Vaximm Secures $835M Licensing Deal for Oral Cancer Immunotherapy VXM01

Baylor College of Medicine to Study Telehealth Genetic Services for Underserved Newborns with $3.5 Million Grant